natgillin/translations-raw huggingface dataset:
Report from the Commission to the European Parliament and the Council under Article 85(2) of Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties and trade repositories, assessing the progress and effort made by CCPs in developing technical solutions for the transfer by pension scheme arrangements of non-cash collateral as variation margins, as well as the need for any measures to facilitate such solution (COM(2015) 39 final of 3 February 2015).
Poročilo Komisije Evropskemu parlamentu in Svetu v skladu s členom 85(2) Uredbe (EU) št. 648/2012 Evropskega parlamenta in Sveta z dne 4. julija 2012 o izvedenih finančnih instrumentih OTC, centralnih nasprotnih strankah in repozitorijih sklenjenih poslov za oceno napredka in prizadevanj CNS pri razvoju tehničnih rešitev glede prenosa negotovinskega zavarovanja kot gibljivega kritja v okviru pokojninskih shem ter morebitne potrebe po ukrepih za omogočanje take rešitve (COM(2015) 39 final z dne 3. februarja 2015).
Commission Implementing Regulation (EU) 2017/611
Izvedbena uredba Komisije (EU) 2017/611
amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2017
o spremembi Uredbe Sveta (ES) št. 297/95 v zvezi s prilagoditvijo pristojbin Evropske agencije za zdravila stopnji inflacije z učinkom od 1. aprila 2017
The inflation rate in the Union, as published by the Statistical Office of the European Union, was 1,2 % in 2016.
Uredbo (ES) št. 297/95 bi bilo zato treba ustrezno spremeniti.
For the sake of simplicity, the adjusted levels of the fees should be rounded to the nearest EUR 100.
Zaradi pravne varnosti se ta uredba ne bi smela uporabljati za veljavne vloge, ki so 1. aprila 2017 še nerešene.
In accordance with Article 12 of Regulation (EC) No 297/95, the update is to be made with effect from 1 April 2017.
Uredba (ES) št. 297/95 se spremeni:
Regulation (EC) No 297/95 is amended as follows:
v prvem pododstavku se „278800 EUR“ nadomesti z „282100 EUR“;
Article 3 is amended as follows:
v drugem pododstavku se „28000 EUR“ nadomesti z „28300 EUR“;
paragraph 1 is amended as follows:
v tretjem pododstavku se „7000 EUR“ nadomesti s „7100 EUR“;
point (a) is amended as follows:
točka (b) se spremeni:
in the first subparagraph, ‘EUR 278800’ is replaced by ‘EUR 282100’,
v prvem pododstavku se „108200 EUR“ nadomesti s „109500 EUR“;
in the second subparagraph, ‘EUR 28000’ is replaced by ‘EUR 28300’,
v drugem pododstavku se „180200 EUR“ nadomesti s „182400 EUR“;
in the third subparagraph, ‘EUR 7000’ is replaced by ‘EUR 7100’,
v tretjem pododstavku se „10800 EUR“ nadomesti z „10900 EUR“;
point (b) is amended as follows:
v četrtem pododstavku se „7000 EUR“ nadomesti s „7100 EUR“;
in the first subparagraph, ‘EUR 108200’ is replaced by ‘EUR 109500’,
točka (c) se spremeni:
in the second subparagraph, ‘EUR 180200’ is replaced by ‘EUR 182400’,
v prvem pododstavku se „83700 EUR“ nadomesti s „84700 EUR“;
in the third subparagraph, ‘EUR 10800’ is replaced by ‘EUR 10900’,
v drugem pododstavku se „20900 EUR do 62700 EUR“ nadomesti z „21200 EUR do 63500 EUR“;
in the fourth subparagraph, ‘EUR 7000’ is replaced by ‘EUR 7100’,
v tretjem pododstavku se „7000 EUR“ nadomesti s „7100 EUR“;
point (c) is amended as follows:
odstavek 2 se spremeni:
in the first subparagraph, ‘EUR 83700’ is replaced by ‘EUR 84700’,
v prvem pododstavku točke (a) se „7000 EUR“ nadomesti s „7100 EUR“;
in the second subparagraph, ‘EUR 20900 to EUR 62700’ is replaced by ‘EUR 21200 to EUR 63500’,
v drugem pododstavku se „20900 EUR do 62700 EUR“ nadomesti z „21200 EUR do 63500 EUR“;
in the third subparagraph, ‘EUR 7000’ is replaced by ‘EUR 7100’;
v odstavku 3 se „13800 EUR“ nadomesti s „14000 EUR“;
paragraph 2 is amended as follows:
v odstavku 4 se „20900 EUR“ nadomesti z „21200 EUR“;
in the first subparagraph of point (a) ‘EUR 7000’ is replaced by ‘EUR 7100’,
v odstavku 5 se „7000 EUR“ nadomesti s „7100 EUR“;
in the second subparagraph, ‘EUR 20900 to EUR 62700’ is replaced by ‘EUR 21200 to EUR 63500’;
odstavek 6 se spremeni:
in paragraph 3, ‘EUR 13800’ is replaced by ‘EUR 14000’;
v prvem pododstavku se „100000 EUR“ nadomesti s „101200 EUR“;
in paragraph 4, ‘EUR 20900’ is replaced by ‘EUR 21200’;
v drugem pododstavku se „24900 EUR do 74900 EUR“ nadomesti s „25200 EUR do 75800 EUR“;
in paragraph 5, ‘EUR 7000’ is replaced by ‘EUR 7100’;
v prvem odstavku člena 4 se „69400 EUR“ nadomesti s „70200 EUR“;
in the first subparagraph, ‘EUR 100000’ is replaced by ‘EUR 101200’,
v prvem pododstavku se „139600 EUR“ nadomesti s „141300 EUR“;
in the second subparagraph, ‘EUR 24900 to EUR 74900’ is replaced by ‘EUR 25200 to EUR 75800’;
v drugem pododstavku se „13800 EUR“ nadomesti s „14000 EUR“;
in the first paragraph of Article 4, ‘EUR 69400’ is replaced by ‘EUR 70200’;
četrti pododstavek se spremeni:
Article 5 is amended as follows:
„69400 EUR“ se nadomesti s „70200 EUR“;
in the first subparagraph, ‘EUR 139600’ is replaced by ‘EUR 141300’,
„7000 EUR“ se nadomesti s „7100 EUR“;
in the second subparagraph, ‘EUR 13800’ is replaced by ‘EUR 14000’,
v prvem pododstavku se „69400 EUR“ nadomesti s „70200 EUR“;
the fourth subparagraph is amended as follows:
v drugem pododstavku se „117800 EUR“ nadomesti s „119200 EUR“;
‘EUR 69400’ is replaced by ‘EUR 70200’,
v tretjem pododstavku se „13800 EUR“ nadomesti s „14000 EUR“;
‘EUR 7000’ is replaced by ‘EUR 7100’;
peti pododstavek se spremeni:
in the first subparagraph, ‘EUR 69400’ is replaced by ‘EUR 70200’,
„34900 EUR“ se nadomesti s „35300 EUR“;
in the second subparagraph, ‘EUR 117800’ is replaced by ‘EUR 119200’,
v prvem pododstavku se „34900 EUR“ nadomesti s „35300 EUR“;
in the third subparagraph, ‘EUR 13800’ is replaced by ‘EUR 14000’,
v drugem pododstavku se „8700 EUR do 26200 EUR“ nadomesti z „8800 EUR do 26500 EUR“;
the fifth subparagraph is amended as follows:
v prvem pododstavku točke (a) se „7000 EUR“ nadomesti s „7100 EUR“;
‘EUR 34900’ is replaced by ‘EUR 35300’,
v prvem pododstavku se „41800 EUR“ nadomesti z „42300 EUR“;
in the first subparagraph, ‘EUR 34900’ is replaced by ‘EUR 35300’,
v drugem pododstavku se „10500 EUR do 31500 EUR“ nadomesti z „10600 EUR do 31900 EUR“;
in the second subparagraph, ‘EUR 8700 to EUR 26200’ is replaced by ‘EUR 8800 to EUR 26500’,
v odstavku 3 se „7000 EUR“ nadomesti s „7100 EUR“;
in the first subparagraph of point (a), ‘EUR 7000’ is replaced by ‘EUR 7100’;
v prvem pododstavku se „33400 EUR“ nadomesti s „33800 EUR“;
in the first subparagraph, ‘EUR 41800’ is replaced by ‘EUR 42300’,
v drugem pododstavku se „8300 EUR do 24900 EUR“ nadomesti z „8400 EUR do 25200 EUR“;
in the second subparagraph, ‘EUR 10500 to EUR 31500’ is replaced by ‘EUR 10600 to EUR 31900’,
v prvem odstavku člena 6 se „41800 EUR“ nadomesti z „42300 EUR“;
in paragraph 3, ‘EUR 7000’ is replaced by ‘EUR 7100’;
člen 7 se spremeni:
in the first subparagraph, ‘EUR 33400’ is replaced by ‘EUR 33800’,
v prvem odstavku se „69400 EUR“ nadomesti s „70200 EUR“;
in the second subparagraph, ‘EUR 8300 to EUR 24900’ is replaced by ‘EUR 8400 to EUR 25200’;
v drugem odstavku se „20900 EUR“ nadomesti z „21200 EUR“;
in the first paragraph of Article 6, ‘EUR 41800’ is replaced by ‘EUR 42300’;
člen 8 se spremeni:
Article 7 is amended as follows:
v drugem pododstavku se „83700 EUR“ nadomesti s „84700 EUR“;
in the first paragraph, ‘EUR 69400’ is replaced by ‘EUR 70200’,
v tretjem pododstavku se „41800 EUR“ nadomesti z „42300 EUR“;
in the second paragraph, ‘EUR 20900’ is replaced by ‘EUR 21200’;
v četrtem pododstavku se „20900 EUR do 62700 EUR“ nadomesti z „21200 EUR do 63500 EUR“;
Article 8 is amended as follows:
v petem pododstavku se „10500 EUR do 31500 EUR“ nadomesti z „10600 EUR do 31900 EUR“;
in the second subparagraph, ‘EUR 83700’ is replaced by ‘EUR 84700’,
v drugem pododstavku se „278800 EUR“ nadomesti z „282100 EUR“;
in the third subparagraph, ‘EUR 41800’ is replaced by ‘EUR 42300’,
v tretjem pododstavku se „139600 EUR“ nadomesti s „141300 EUR“;
in the fourth subparagraph, ‘EUR 20900 to EUR 62700’ is replaced by ‘EUR 21200 to EUR 63500’,
v petem pododstavku se „3000 EUR do 240300 EUR“ nadomesti s „3000 EUR do 243200 EUR“;
in the fifth subparagraph, ‘EUR 10500 to EUR 31500’ is replaced by ‘EUR 10600 to EUR 31900’;
v šestem pododstavku se „3000 EUR do 120300 EUR“ nadomesti s „3000 EUR do 121700 EUR“;
in the second subparagraph, ‘EUR 278800’ is replaced by ‘EUR 282100’,
v prvem pododstavku odstavka 3 se „7000 EUR“ nadomesti s „7100 EUR“.
in the third subparagraph, ‘EUR 139600’ is replaced by ‘EUR 141300’,
Člen 2
in the fifth subparagraph, ‘EUR 3000 to EUR 240300’ is replaced by ‘EUR 3000 to EUR 243200’,
Ta uredba se ne uporablja za veljavne vloge, ki so 1. aprila 2017 še nerešene.
in the sixth subparagraph, ‘EUR 3000 to EUR 120300’ is replaced by ‘EUR 3000 to EUR 121700’;
Člen 3
in the first subparagraph of paragraph 3, ‘EUR 7000’ is replaced by ‘EUR 7100’.
Ta uredba začne veljati na dan po objavi v Uradnem listu Evropske unije.
Article 2
Uporablja se od 1. aprila 2017.
This Regulation shall not apply to valid applications pending on 1 April 2017.
Ta uredba je v celoti zavezujoča in se neposredno uporablja v vseh državah članicah.
Article 3
V Bruslju, 30. marca 2017
It shall apply from 1 April 2017.
Predsednik
Done at Brussels, 30 March 2017.
Uredba (ES) št. 726/2004 Evropskega parlamenta in Sveta z dne 31. marca 2004 o postopkih Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za humano in veterinarsko uporabo ter o ustanovitvi Evropske agencije za zdravila (UL L 136, 30.4.2004, str. 1).
For the Commission
Navedene pristojbine bi bilo treba prilagoditi s sklicevanjem na stopnjo inflacije leta 2016.
The President
Stopnja inflacije v Uniji, kakor jo je objavil Statistični urad Evropske unije, je leta 2016 znašala 1,2 %.
OJ L 35, 15.2.1995, p. 1.
V skladu s členom 12 Uredbe (ES) št. 297/95 je treba prilagoditev izvesti z učinkom od 1. aprila 2017.
Commission Implementing Regulation (EU) 2017/613
Izvedbena uredba Komisije (EU) 2017/613
Commission Implementing Regulation (EU) 2017/616
Izvedbena uredba Komisije (EU) 2017/616
amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, amitraz, coumaphos, diflufenican, flumequine, metribuzin, permethrin, pyraclostrobin and streptomycin in or on certain products
o spremembi prilog II in III k Uredbi Evropskega parlamenta in Sveta (ES) št. 396/2005 glede mejnih vrednosti ostankov za acekvinocil, amitraz, kumafos, diflufenikan, flumekvin, metribuzin, permetrin, piraklostrobin in streptomicin v ali na nekaterih proizvodih
For diflufenican and pyraclostrobin, maximum residue levels (MRLs) were set in Annex II to Regulation (EC) No 396/2005.
Mejne vrednosti ostankov (v nadaljnjem besedilu: MRL) za diflufenikan in piraklostrobin so bile določene v Prilogi II k Uredbi (ES) št. 396/2005.
For amitraz and permethrin, MRLs were set in Annex II and Part B of Annex III to that Regulation.
Za amitraz in permetrin so bile MRL določene v Prilogi II in delu B Priloge III k navedeni uredbi.
For acequinocyl and metribuzin, MRLs were set in Part A of Annex III to that Regulation.
Za acekvinocil in metribuzin so bile MRL določene v delu A Priloge III k navedeni uredbi.
For coumaphos, flumequine and streptomycin, no specific MRLs were set nor were those substances included in Annex IV to that Regulation, so the default value of 0,01 mg/kg laid down in Article 18(1)(b) thereof applies.
Kar zadeva kumafos, flumekvin in streptomicin, niso bile določene posebne MRL in navedene snovi niso bile vključene v Prilogo IV k navedeni uredbi, tako da se uporablja privzeta vrednost 0,01 mg/kg iz člena 18(1)(b) navedene uredbe.
In the context of a procedure for the authorisation of the use of a plant protection product containing the active substance acequinocyl on gherkins, an application was submitted in accordance with Article 6(1) of Regulation (EC) No 396/2005 for modification of the existing MRL.
V okviru postopka za registracijo fitofarmacevtskega sredstva, ki vsebuje aktivno snov acekvinocil, za uporabo na kumaricah za vlaganje je bila v skladu s členom 6(1) Uredbe (ES) št. 396/2005 vložena vloga za spremembo obstoječe MRL.
As regards diflufenican and metribuzin, such an application was submitted for olives for oil production.
Za diflufenikan in metribuzin je bila taka vloga vložena za oljke za proizvodnjo olja.
As regards pyraclostrobin, such an application was submitted for chards.
Za piraklostrobin je bila taka vloga vložena za liste blitve.
It forwarded those opinions to the applicants, the Commission and the Member States and made them available to the public.
Navedena mnenja je poslala vložnikom, Komisiji in državam članicam ter jih javno objavila.
As regards all those applications, the Authority concluded that all requirements with respect to data were met and that the modifications to the MRLs requested by the applicants were acceptable with regard to consumer safety on the basis of a consumer exposure assessment for 27 specific European consumer groups.
Agencija je glede vseh navedenih vlog ugotovila, da v celoti izpolnjujejo zahteve po podatkih in da so spremembe MRL, ki jih zahtevajo vložniki, sprejemljive z vidika varnosti potrošnikov na podlagi ocene izpostavljenosti potrošnikov za 27 posebnih skupin evropskih potrošnikov.
Amitraz, flumequine, permethrin and streptomycin are pharmacologically active substances in veterinary medicine.
Amitraz, flumekvin, permetrin in streptomicin so farmakološko aktivne snovi v veterinarski medicini.
As regards products of animal origin, MRLs should be set in Regulation (EC) No 396/2005 at the same levels as provided for in Commission Regulation (EU) No 37/2010 [3] because exposure from use in veterinary medicinal products is expected to be higher than from use in plant protection products.
MRL za proizvode živalskega izvora bi bilo treba določiti v Uredbi (ES) št. 396/2005 na ravni iz Uredbe Komisije (EU) št. 37/2010 [3], saj se pričakuje, da je izpostavljenost pri uporabi v zdravilih za uporabo v veterinarski medicini, večja kot pri uporabi v fitofarmacevtskih sredstvih.
Those MRLs are safe for consumers in the Union [4].
Navedene MRL so varne za potrošnike v Uniji [4].
As regards coumaphos, the Authority identified concerns in relation to the chronic risk assessment, which need to be addressed by means of a risk management decision.
V zvezi s kumafosom ima Agencija pomisleke pri oceni kroničnega tveganja, ki jih je treba obravnavati v odločitvi o obvladovanju tveganja.
Taking into account that Regulation (EU) No 37/2010 sets an MRL for coumaphos only in honey and considering the low contribution of that product to the chronic consumer exposure, it is appropriate to set the MRL for honey and other apiculture products in Regulation (EC) No 396/2005 at the same level.
Ob upoštevanju, da Uredba (EU) št. 37/2010 določa MRL za kumafos samo v medu in da navedeni proizvod malo prispeva h kronični izpostavljenosti potrošnikov, je v Uredbi (ES) št. 396/2005 primerno določiti MRL za med in druge čebelarske proizvode na isti ravni.
EFSA scientific reports available online: http://www.efsa.europa.eu:Reasoned opinion on the modification of the existing maximum residue level for acequinocyl in gherkins.
Znanstvena poročila Agencije so na voljo na spletu: http://www.efsa.europa.eu:Reasoned opinion on the modification of the existing maximum residue level for acequinocyl in gherkins (Obrazloženo mnenje o spremembi obstoječe mejne vrednosti ostanka za acekvinocil v kumaricah za vlaganje).
EFSA Journal 2016;14(8):4568 [13 pp.].Reasoned opinion on the modification of the existing maximum residue level for diflufenican in olives for oil production.
EFSA Journal 2016;14(8):4568 [13 str.].Reasoned opinion on the modification of the existing maximum residue level for diflufenican in olives for oil production (Obrazloženo mnenje o spremembi obstoječe mejne vrednosti ostanka za diflufenikan v oljkah za proizvodnjo olja).
EFSA Journal 2016;14(10):4585 [15 pp.].Reasoned opinion on the modification of the existing maximum residue level for metribuzin in olives for oil production.
EFSA Journal 2016;14(10):4585 [15 str.].Reasoned opinion on the modification of the existing maximum residue level for metribuzin in olives for oil production (Obrazloženo mnenje o spremembi obstoječe mejne vrednosti ostanka za metribuzin v oljkah za proizvodnjo olja).
EFSA Journal 2016;14(8):4552 [14 pp.].
Reasoned opinion on the setting of maximum residue levels for amitraz, coumaphos, flumequine, oxytetracycline, permethrin and streptomycin in certain products of animal origin (Obrazloženo mnenje o določitvi mejnih vrednosti ostankov za amitraz, kumafos, flumekvin, oksitetraciklin, permetrin in streptomicin v nekaterih proizvodih živalskega izvora).
Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).
EFSA Journal 2016;14(8):4570 [39 str.].
Reasoned opinion on the setting of maximum residue levels for amitraz, coumaphos, flumequine, oxytetracycline, permethrin and streptomycin in certain products of animal origin.
PRILOGA
EFSA Journal 2016;14(8):4570 [39 pp.].
Prilogi II in III k Uredbi (ES) št. 396/2005 se spremenita:
Annexes II and III to Regulation (EC) No 396/2005 are amended as follows:
stolpci za amitraz, diflufenikan, permetrin in piraklostrobin se nadomestijo z naslednjim:
Annex II is amended as follows:
„Ostanki pesticidov in mejne vrednosti ostankov (mg/kg)
the columns for amitraz, diflufenican, permethrin and pyraclostrobin are replaced by the following:
topen v maščobi
Fat soluble
(+) Evropska agencija za varnost hrane je za nekatere informacije o obstojnosti pri shranjevanju navedla, da niso na voljo.
Diflufenican (F)
Pri pregledu MRL bo Komisija upoštevala informacije iz prvega stavka, če bodo predložene do 17. aprila 2017, če pa navedene informacije do navedenega datuma ne bodo predložene, bo upoštevala, kot da jih ni.
(+) The European Food Safety Authority identified some information on storage stability as unavailable.
Citrusi
When re-viewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 17 April 2017, or, if that information is not submitted by that date, the lack of it.
Grenivke
Almonds
Pečkato sadje
Peaches
(+) Evropska agencija za varnost hrane je za nekatere informacije o obstojnosti pri shranjevanju, poskusih za ugotavljanje ostankov in dobri zunanji kmetijski praksi na severu navedla, da niso na voljo.
(+) The European Food Safety Authority identified some information on storage stability, residue trials and the northern outdoor Good Agricultural Practice as unavailable.
Namizno grozdje
Table grapes
Kiviji/aktinidije (zeleni, rdeči, rumeni)
Wine grapes
(+) Veljavna mejna vrednost ostanka za hren (Armoracia rusticana) v skupini Začimbe (oznaka 0840040) je enaka vrednosti za hren (Armoracia rusticana) v skupini Zelenjava – korenovke in gomoljnice (oznaka 0213040), pri čemer se v skladu s členom 20(1) Uredbe (ES) št. 396/2005 upoštevajo spremembe v vrednostih ostankov, ki so posledica predelave (sušenja).
Kiwi fruits (green, red, yellow)
Hren
(+) The European Food Safety Authority identified some information on analytical methods as unavailable.
Maščevje
Sheep
Piraklostrobin (F)
Goat
(+) Evropska agencija za varnost hrane je za nekatere informacije o poskusih za ugotavljanje ostankov navedla, da niso na voljo.
(+) The European Food Safety Authority identified some information on residue trials as unavailable.
Belušna zelena
When re-viewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 13 July 2015, or, if that information is not submitted by that date, the lack of it.
Kavna zrna
Celeries
Hren“
Coffee beans
Številčna oznaka
Code number
Amitraz (amitraz, vključno z metaboliti, ki vsebujejo delež 2,4-dimetilanilina, izražen kot amitraz)
Groups and examples of individual products to which the MRLs apply [2]
Permetrin (vsota izomerov) (F)
Amitraz (amitraz including the metabolites containing the 2,4 -dimethylaniline moiety expressed as amitraz)
SVEŽE ALI ZAMRZNJENO SADJE, LUPINARJI
Permethrin (sum of isomers) (F)
Lupinarji
Pine nut kernels
Jagodičje in drobno sadje
Pistachios
Jagode
Rye
ČAJ, KAVA, ZELIŠČNI ČAJI, KAKAV IN ROŽIČI
Rooibos
Kateri koli drugi deli rastline
Ginseng
ZAČIMBE
Quail
dodajo se naslednji stolpci za kumafos, flumekvin in streptomicin:
Amphibians and Reptiles
Skupine in primeri posameznih proizvodov, za katere veljajo MRL [3]
Terrestrial invertebrate animals
Kumafos
the following columns for coumaphos, flumequine and streptomycin are added:
Streptomicin
Indicates lower limit of analytical determination
Priloga III se spremeni:
Groups and examples of individual products to which the MRLs apply [3]
v delu A se stolpca za acekvinocil in metribuzin nadomestita z naslednjim:
Coumaphos
Acekvinocil
Flumequine
Skupine in primeri posameznih proizvodov, za katere veljajo MRL [5]
Streptomycin
v delu B se črtata stolpca za amitraz in permetrin.
Annex III is amended as follows:
Za popoln seznam proizvodov rastlinskega in živalskega izvora, za katere veljajo MRL, se je treba sklicevati na Prilogo I.
in Part A, the columns for acequinocyl and metribuzin are replaced by the following:
Za popoln seznam proizvodov rastlinskega in živalskega izvora, za katere veljajo MRL, se je treba sklicevati na Prilogo I.“
Acequinocyl
EFSA Journal 2016;14(10):4591 [13 str.].Reasoned opinion on the modification of the existing maximum residue level for pyraclostrobin in beet leaves (chards) (Obrazloženo mnenje o spremembi obstoječe mejne vrednosti ostanka za piraklostrobin v listih blitve).
amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, daminozide and tolylfluanid in or on certain products
o spremembi prilog II in V k Uredbi Evropskega parlamenta in Sveta (ES) št. 396/2005 glede mejnih vrednosti ostankov za bifenazat, daminozid in tolilfluanid v ali na nekaterih proizvodih
Having regard to Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC [1], and in particular Article 14(1)(a) and Article 18(1)(b) thereof,
ob upoštevanju Uredbe Evropskega parlamenta in Sveta (ES) št. 396/2005 z dne 23. februarja 2005 o mejnih vrednostih ostankov pesticidov v ali na hrani in krmi rastlinskega in živalskega izvora ter o spremembi Direktive Sveta 91/414/EGS [1] in zlasti člena 14(1)(a) in člena 18(1)(b) Uredbe,
For bifenazate maximum residue levels (MRLs) were set in Annex II to Regulation (EC) No 396/2005.
Mejne vrednosti ostankov (v nadaljnjem besedilu: MRL) za bifenazat so bile določene v Prilogi II k Uredbi (ES) št. 396/2005.
For daminozide and tolylfluanid MRLs were set in Annex V to that Regulation.
Za daminozid in tolilfluanid so bile MRL določene v Prilogi V k navedeni uredbi.
For bifenazate, the European Food Safety Authority, hereinafter ‘the Authority’, submitted a reasoned opinion on the existing MRLs in accordance with Article 12(2) of Regulation (EC) No 396/2005 in conjunction with Article 12(1) thereof [2] By Regulation (EU) No 79/2014 [3] the recommendations of the Authority on the review of the existing MRLs were implemented.
Za bifenazat je Evropska agencija za varnost hrane (v nadaljnjem besedilu: Agencija) predložila obrazloženo mnenje glede obstoječih MRL v skladu s členom 12(2) Uredbe (ES) št. 396/2005 v povezavi s členom 12(1) Uredbe [2].
For daminozide, the Authority, submitted a reasoned opinion on the existing MRLs in accordance with Article 12(1) of Regulation (EC) No 396/2005 [4] By Regulation (EU) No 87/2014 [5] the recommendations of the Authority on the review of the existing MRLs were implemented.
Priporočila Agencije o pregledu obstoječih MRL so bila izvedena z Uredbo (EU) št. 79/2014 [3].